NCT01933568View on ClinicalTrials.gov

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 11, 2018

Study Completion Date

November 11, 2018

Conditions
Inoperable Locally Advanced Non Small Cell Lung Cancer
Interventions
RADIATION

SABR

combined CFRT and SABR with concurrent cisplatin

DRUG

Cisplatin

combined CFRT and SABR with concurrent cisplatin

Trial Locations (1)

1066 CX

The Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT01933568 - Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. | Biotech Hunter | Biotech Hunter